Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
This is a Phase 3 global, multicenter, 52-week, open-label extension (OLE) rollover study for subjects completing study CN012-0026, CN012-0027 or CN012-0056. Subjects (randomized or non-randomized) who complete the 38-week CN012-0026 study, 14-week CN012-0027 study or 14-week CN012-0056 study will be eligible to enroll in CN012-0028. The primary objective of the study is to assess the long-term safety and tolerability of KarXT in subjects with psychosis associated with Alzheimer's Disease.
Inclusion Criteria:
Must have completed study KAR-031 (CN012-0026), KAR-032(CN012-0027), or CN012-0056. This Inclusion criterion is not applicable for Protocol Amendment 07 or later versions.
Can understand the nature of the study and protocol requirements and provide a signed informed consent (IC) form before any study assessments are performed. If the subject is deemed not competent to provide IC, both the following requirements for consent must be met:
Must have stable living environment. At entry into this study, or any time during the study, if a subject needs to relocate from home, a residential assisted-living facility, or other stable location to a nursing home facility, the Sponsor/Medical Monitor must approve the subject's participation in the study.
Exclusion Criteria:
Clinical.Trials@bms.com855-907-3286
Los Angeles, California 90033-5313, United States
Walnut Creek, California 94596, United States
Hialeah, Florida 33012-4648, United States
Homestead, Florida 33033, United States
Miami, Florida 33173-1474, United States
Tampa, Florida 33614-2869, United States
West Palm Beach, Florida 33407-3209, United States
Woodmere, New York 11598-1739, United States
Ciudad Autónoma de Buenos Aires, Buenos Aires 1056, Argentina
Ciudad Autónoma de Buenos Aires, Buenos Aires C1012AAR, Argentina
Ciudad Autónoma de Buenos Aires, Buenos Aires C1058AAJ, Argentina
Ciudad Autónoma de Buenos Aires, Buenos Aires C1107, Argentina
Plovdiv, 4001, Bulgaria
Beijing, Beijing Municipality 100088, China
Guangzhou, Guangdong 0, China
Nanjing, Jiangsu 210011, China
Tianjin, Tianjin Municipality 300222, China
Hangzhou, Zhejiang 310016, China
Rouen, Seine-Maritime 76031, France
Chaidari, Athens, Attica 12462, Greece
Kalyftaki-N. Kifissia, Attica 145 64, Greece
Chandigarh, Punjab 160012, India
Ashkelon, Tel Aviv 7830604, Israel
Baggiovara, Modena 41126, Italy
Himeji-Shi, Hyōgo 672-8044, Japan
Toride-shi, Ibaraki 302-0004, Japan
Toride-shi, Ibaraki 302-0004, Japan
+297796166
Kawasaki-Shi, Kanagawa 210-0852, Japan
81443668900
Setagaya-Ku, Tokyo 154-0004, Japan
Setagaya-Ku, Tokyo 156-0041, Japan
81333277462
Setagaya-Ku, Tokyo 156-0057, Japan
Saltillo Centro, Coahuila 25000, Mexico
528441258992
Zona Urbana Río Tijuana, Estado de Baja California 22010, Mexico
Poznan, Greater Poland Voivodeship 61-485, Poland
Lódz, Lódzkie 90-349, Poland
+48602242959
Gdansk, Pomeranian Voivodeship 80-214, Poland
Ścinawa, 59-330, Poland
Oradea, Bihor County 410027, Romania
Bucharest, 40874, Romania
Gornja Toponica, 705631, Serbia
Košice, Košice Region 041 90, Slovakia
Buk-gu, Daegu Gwang'yeogsi 41404, South Korea
Yeongdeungpo-gu, Seoul Teugbyeolsi 07345, South Korea
Gangwon-do, 200-704, South Korea
821041512959
Atakum, Samsun 55139, Turkey (Türkiye)
714-999-6688
323-442-3715
626-250-2070
925-298-5147
860-790-7354
305-819-2909
321-500-5252
305-424-8696
386-278-8000
305-888-0410
786-741-2287
305-828-3555
305-456-7782
786-334-6675
305-805-0921
786-715-2200
786-422-7374
407-670-5833
305-445-5994
786-218-1733
208-346-8900
786-238-7099
305-223-2000
305-326-0776
305-359-7666
866-879-2507
786-359-4867
305-888-0410
786-801-0912
305-669-6166
000-000-0000
305-263-7120
305-551-8493
305-596-2080
786-600-7005
305-892-1035
305-392-0244
000-000-0000
786-808-0832
305-269-7100
305-705-4494
305-885-8983
407-823-8421
407-440-4493
386-673-2500
813-931-0128
813-300-3300
813-251-1800
561-845-0500
404-382-8660
601-420-5810
516-239-1800
704-364-4000
949-491-0710
713-484-6947
558888888888
+551938639438
5521999822072
+35964910999
359888793906
+359888220704
+56226758700
+56552240334
+56222016979
8613811591959
+862081580392
+861355619953
8613632587615
8618951762651
+861377427254
+861898060171
+8615122889423
+8613958024692
+86 138 0573 6335
38598541880
+38513780678
+420222510607
420777551077
420777242101
+33232888740
+390593962201
0456286100
81457872800
81-75-461-5121
0722294882
+528181232436
+526677587952
48604116632
48583493720
+48793418181
+48609034771
0040747056934
+40745588989
4026944141x5
+381637708765
381113609206
382+11
+38163529054
+38163685994
+421556152721
+421484124549
+421424426231
+421556402727
+421574880251
+82-2-2072-2193
82226505298
+82222908374
+34923126580
+34679279973
+34670492099